MEMBRAN: Study of the Role of the Induced Membrane in the Reconstruction of Bone Loss in the Limbs

Sponsor
Direction Centrale du Service de Santé des Armées (Other)
Overall Status
Recruiting
CT.gov ID
NCT04883502
Collaborator
(none)
80
2
77.1
40
0.5

Study Details

Study Description

Brief Summary

Masquelet's induced membrane technique is a two-stage reconstructive surgery for severe bone fractures commonly used by military orthopedists. The particularity of this technique relies on the synthesis of a biological membrane induced by the transient implantation of a surgical cement (= 1st stage surgery). The presence of the induced membrane in the reconstruction space defines a microenvironment or "biological chamber" favourable to osteogenesis, positively influencing the repair of the lesion after implantation of an autologous bone graft (= 2nd stage of surgery).

In view of the excellent clinical results obtained with this procedure, the Masquelet technique has gradually become a reference treatment in the field of orthopedic and trauma surgery.

However, orthopedic surgeons sometimes observe failures in bone consolidation. To our knowledge, the role played by induced membrane in these therapeutic failures has never been studied.

Condition or Disease Intervention/Treatment Phase
  • Biological: Blood sample collection
  • Biological: Other biological sample collection
  • Diagnostic Test: Surgical waste collection
  • Diagnostic Test: Radiological examination and functional exploration

Study Design

Study Type:
Observational
Anticipated Enrollment :
80 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Study of the Role of the Induced Membrane in the Reconstruction of Bone Loss in the Limbs
Actual Study Start Date :
Oct 29, 2021
Anticipated Primary Completion Date :
Apr 1, 2028
Anticipated Study Completion Date :
Apr 1, 2028

Outcome Measures

Primary Outcome Measures

  1. Histological profile of induced membrane fragments [Through study completion, an average of 6,5 years]

    Presence of abnormalities in the organization of connective fibers. The profile of induced membrane fragments will be compared between patients who respond and patients who do not respond to the induced membrane technique.

  2. Cellular profile of induced membrane fragments [Through study completion, an average of 6,5 years]

    Presence of mesenchymal stromal cells, ability of these cells to differentiate into osteoblasts, presence of other cell types (such as adipocytes and osteoclasts). The profile of induced membrane fragments will be compared between patients who respond and patients who do not respond to the induced membrane technique.

  3. Secretory profile of induced membrane fragments [Through study completion, an average of 6,5 years]

    Determination of proteins secreted by the induced membrane fragments by mass spectrometry or by enzyme-linked immunosorbent assay. The profile of induced membrane fragments will be compared between patients who respond and patients who do not respond to the induced membrane technique.

  4. Gene expression profile of induced membrane fragments [Through study completion, an average of 6,5 years]

    Expression of several genes of interest related to angiogenesis, mesenchymal stromal cells mobilization, bone formation or resorption and extracellular matrix remodeling. The profile of induced membrane fragments will be compared between patients who respond and patients who do not respond to the induced membrane technique.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Age ≥ 18 years

  • Patient with traumatic bone loss

  • Patient eligible for the induced membrane technique

Exclusion Criteria:
  • Patients with post-tumor bone loss

  • Patients who are immunocompromised or under immunosuppressive treatment

  • Patients with chronic inflammatory disease (diabetes, inflammatory bowel disease)

  • Patients with collagenosis

  • Patient with a contraindication to sampling

  • Pregnant or breastfeeding women

Contacts and Locations

Locations

Site City State Country Postal Code
1 Hôpital d'Instruction des Armées Percy Clamart France 92140
2 Hôpital d'Instruction des Armées Bégin Saint-Mandé France 94160

Sponsors and Collaborators

  • Direction Centrale du Service de Santé des Armées

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Direction Centrale du Service de Santé des Armées
ClinicalTrials.gov Identifier:
NCT04883502
Other Study ID Numbers:
  • 2019PPRC03
  • 2021-A00561-40
First Posted:
May 12, 2021
Last Update Posted:
Dec 13, 2021
Last Verified:
Dec 1, 2021
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Direction Centrale du Service de Santé des Armées
Additional relevant MeSH terms:

Study Results

No Results Posted as of Dec 13, 2021